EGFR and non-small cell lung carcinoma: In all patients with advanced NSCLC and unusual lung squamous-cell carcinomas, it is recommended to perform standard genome sequencing including KRAS, EGFR, ALK, ROS1, NTRK, RET, MET, BRAF and HER2.